CancerPathwayFinder_700x233

Liquid biopsy: a necessity in the age of personalized medicine

The 2001 introduction of Imatinib (Gleevec) for the treatment of chronic myelogenous leukemia was a watershed moment in cancer therapeutics. In addition to treating a previously fatal leukemia, it opened the door for the further development of targeted therapeutics, molecules designed to specifically inhibit individual oncogenic proteins. The advent of targeted therapy also made the… Read article →


S_1997_FFPE_s

Top 5 considerations for preparing and archiving FFPE samples

The archives of formalin-fixed paraffin-embedded (FFPE) tissue sections stored around the world represent a valuable and extensive source of material for biomedical research. With more researchers turning towards molecular analysis of FFPE samples, it is becoming increasingly important to develop specific protocols that take into consideration the unique nature of these samples. The complete FFPE… Read article →




targeted DNA sequencing

Targeted DNA sequencing: why you might miss some mutations

One of our favorite things here at QIAGEN is the concept of targeted DNA sequencing. If you haven’t heard about it yet, it’s an approach that involves enriching specific regions of a gene prior to NGS. More scientists have been adopting this strategy recently because it has three key advantages over whole-genome sequencing. Namely, targeted… Read article →